Prolific Machines

company

About

Prolific Machines is a biotech company developing cell technologies to redefine how cells are produced for a sustainable and healthy future.

Details

Last Funding Type
Series A
Last Funding Money Raised
$42M
Industries
Biotechnology,Health Care,Life Science,Therapeutics
Founded date
Jan 1, 2020
Number Of Employee
1 - 10
Operating Status
Active
Also Known As
Gaia Laboratories

Prolific Machines is a biotech company developing cell technologies to redefine how cells are produced for a sustainable and healthy future. It combines cutting-edge technologies to enable cell production at a new scale.

The company was founded in 2020 and is based in San Francisco, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
7
$42M
Prolific Machines has raised a total of $42M in funding over 2 rounds. Their latest funding was raised on Dec 7, 2022 from a Convertable Note round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 7, 2022 Convertable Note 2 Detail
Sep 14, 2022 Series A $42M 12 Breakthrough Energy Ventures Detail
Nov 19, 2021 Seed 1 Detail
Mar 22, 2021 Seed 2 Detail
Jul 14, 2020 Convertable Note 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
14
Prolific Machines is funded by 14 investors. Breakthrough Energy Ventures and IndieBio are the most recent investors.
Investor Name Lead Investor Funding Round
Breakthrough Energy Ventures Yes Series A
IndieBio Convertable Note
SOSV Convertable Note
Baruch Future Ventures Series A
Breyer Capital Series A
David Adelman Series A
David Rubenstein Series A
Frederick Blackford Series A
Jacob Poliskin Series A
Mark Cuban Series A

Employee Profiles

Number of Employee Profiles
4
Prolific Machines has 4 current employee profiles, including Executive Deniz Kent
Executive
Executive
Executive
Executive